During the past decade, WellSpan Gynecologic Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "WellSpan Gynecologic Oncology" #1 collaborator was "GOG Foundation" with 2 trials as a collaborator and "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "WellSpan Gynecologic Oncology" are "Cervical Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials), "Ovarian Cancer" (1 trials) and "Peritoneal Neoplasms" (1 trials). Many other conditions were trialed in "WellSpan Gynecologic Oncology" in a lesser frequency.

Most popular intervention types in "WellSpan Gynecologic Oncology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "AGEN1884" (1 trials), "AGEN2034" (1 trials), "Atezolizumab" (1 trials), "Atezolizumab Placebo" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "WellSpan Gynecologic Oncology" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "WellSpan Gynecologic Oncology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in WellSpan Gynecologic Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in WellSpan Gynecologic Oncology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".